UB Paderborn / Katalog / Suche / in CDI

A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making

Cytotherapy (Oxford, England), 2018-06, Vol.20 (6), p.769-778

2018

Link zum Volltext

Verfügbarkeit prüfen

Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death

European heart journal, 2005-03, Vol.26 (6), p.590-597

2005

Link zum Volltext

Verfügbarkeit prüfen

Differences in external price referencing in Europe—A descriptive overview

Health policy (Amsterdam), 2012-01, Vol.104 (1), p.50-60

2012

Link zum Volltext

Verfügbarkeit prüfen

Psychoactive substance use and the risk of motor vehicle accidents

Accident analysis and prevention, 2004-07, Vol.36 (4), p.631-636

2004

Link zum Volltext

Verfügbarkeit prüfen

Use of oral corticosteroids in the United Kingdom

QJM : An International Journal of Medicine, 2000-02, Vol.93 (2), p.105-111

2000

Link zum Volltext

Verfügbarkeit prüfen

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids

QJM : An International Journal of Medicine, 2005-03, Vol.98 (3), p.191-198

2005

Link zum Volltext

Verfügbarkeit prüfen

Applicability Of Eunethta Relative Effectiveness Assessment of Pazopanib For National Assessments

Value in health, 2014-11, Vol.17 (7), p.A661-A662

2014

Link zum Volltext

Verfügbarkeit prüfen

Placebo response in antipsychotic trials of patients with acute mania

European neuropsychopharmacology, 2015-07, Vol.25 (7), p.1018-1026

2015

Link zum Volltext

Verfügbarkeit prüfen

N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease

The European respiratory journal, 2003-05, Vol.21 (5), p.795-798

2003

Link zum Volltext

Verfügbarkeit prüfen

Hospital discharge diagnoses of ventricular arrhythmias and cardiac arrest were useful for epidemiologic research

Journal of clinical epidemiology, 2005-12, Vol.58 (12), p.1325-1329

2005

Link zum Volltext

Verfügbarkeit prüfen

Utility of medical and drug history in fracture risk prediction among men and women

Bone (New York, N.Y.), 2002-10, Vol.31 (4), p.508-514

2002

Link zum Volltext

Verfügbarkeit prüfen

The use of real-world data in cancer drug development

European journal of cancer (1990), 2018-09, Vol.101, p.69-76

2018

Link zum Volltext

Verfügbarkeit prüfen

O2.17: Available and clinically applicable information for rational drug prescribing to older patients in European and American compendia

European geriatric medicine, 2014-09, Vol.5, p.S60-S61

2014

Link zum Volltext

Verfügbarkeit prüfen

Views of clinical and non-clinical professionals on information about older patients needed for rational drug prescription at time of authorisation

European geriatric medicine, 2013-09, Vol.4, p.S178-S178

2013

Link zum Volltext

Verfügbarkeit prüfen

The number of included older people in recent pre-approval trials

European geriatric medicine, 2013-09, Vol.4, p.S178-S178

2013

Link zum Volltext

Verfügbarkeit prüfen

Neutropenia and agranulocytosis in England and Wales: Incidence and risk factors

American journal of hematology, 2003-04, Vol.72 (4), p.248-254

2003

Link zum Volltext

Verfügbarkeit prüfen

Hip / knee arthroplasty and risk of hip fracture: A population-based case-control study

Bone (New York, N.Y.), 2010-06, Vol.47, p.S29-S29

2010

Link zum Volltext

Verfügbarkeit prüfen

Risk of hip fracture after stroke: A population-based case-control study

Bone (New York, N.Y.), 2009-06, Vol.44, p.S416-S417

2009

Link zum Volltext

Verfügbarkeit prüfen

O2.21: Practical problems with medication use experienced by older people: a qualitative study

European geriatric medicine, 2014-09, Vol.5, p.S62-S62

2014

Link zum Volltext

Verfügbarkeit prüfen

The EU regulatory landscape of non-biological complex drugs (NBCDs) follow-on products: Observations and recommendations

European journal of pharmaceutical sciences, 2019-05, Vol.133, p.228-235

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmaceutical Scientists’ Perspectives on Capacity Building in Pharmaceutical Sciences

Journal of pharmaceutical sciences, 2023-07, Vol.112 (7), p.1997-2003

2023

Link zum Volltext

Verfügbarkeit prüfen

Unmet Medical Need as a Driver for Pharmaceutical Sciences – A Survey Among Scientists

Journal of pharmaceutical sciences, 2022-05, Vol.111 (5), p.1318-1324

2022

Link zum Volltext

Verfügbarkeit prüfen

From HMG through purified urinary FSH preparations to recombinant FSH: a substitution study

Human reproduction (Oxford), 2002-04, Vol.17 (4), p.857-865

2002

Link zum Volltext

Verfügbarkeit prüfen

Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case–control study using spontaneous reports

International clinical psychopharmacology, 2002-03, Vol.17 (2), p.75-79

2002

Link zum Volltext

Verfügbarkeit prüfen

PDG61 Incorporating Uncertainty in Clinical Benefit in Health Technology Assessments: A Review and Classification of Agency Approaches

Value in health, 2020-12, Vol.23, p.S529-S529

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making

Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death

Differences in external price referencing in Europe—A descriptive overview

Psychoactive substance use and the risk of motor vehicle accidents

Use of oral corticosteroids in the United Kingdom

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids

Applicability Of Eunethta Relative Effectiveness Assessment of Pazopanib For National Assessments

Placebo response in antipsychotic trials of patients with acute mania

N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease

Hospital discharge diagnoses of ventricular arrhythmias and cardiac arrest were useful for epidemiologic research

Utility of medical and drug history in fracture risk prediction among men and women

The use of real-world data in cancer drug development

O2.17: Available and clinically applicable information for rational drug prescribing to older patients in European and American compendia

Views of clinical and non-clinical professionals on information about older patients needed for rational drug prescription at time of authorisation

The number of included older people in recent pre-approval trials

Neutropenia and agranulocytosis in England and Wales: Incidence and risk factors

Hip / knee arthroplasty and risk of hip fracture: A population-based case-control study

Risk of hip fracture after stroke: A population-based case-control study

O2.21: Practical problems with medication use experienced by older people: a qualitative study

The EU regulatory landscape of non-biological complex drugs (NBCDs) follow-on products: Observations and recommendations

Pharmaceutical Scientists’ Perspectives on Capacity Building in Pharmaceutical Sciences

Unmet Medical Need as a Driver for Pharmaceutical Sciences – A Survey Among Scientists

From HMG through purified urinary FSH preparations to recombinant FSH: a substitution study

Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case–control study using spontaneous reports

PDG61 Incorporating Uncertainty in Clinical Benefit in Health Technology Assessments: A Review and Classification of Agency Approaches

Suchergebnisse filtern